Samsara BioCapital as of Sept. 30, 2025
Portfolio Holdings for Samsara BioCapital
Samsara BioCapital holds 27 positions in its portfolio as reported in the September 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Mineralys Therapeutics (MLYS) | 31.0 | $238M | 6.3M | 37.92 | |
| Scholar Rock Hldg Corp (SRRK) | 27.3 | $209M | 5.6M | 37.24 | |
| Kalaris Therapeutics (KLRS) | 8.6 | $66M | 11M | 5.78 | |
| Septerna (SEPN) | 7.7 | $59M | 3.1M | 18.81 | |
| Neurogene (NGNE) | 3.9 | $30M | 1.7M | 17.33 | |
| Alumis (ALMS) | 2.5 | $19M | 4.8M | 3.99 | |
| Upstream Bio (UPB) | 2.4 | $18M | 962k | 18.81 | |
| Gossamer Bio (GOSS) | 2.1 | $16M | 6.1M | 2.63 | |
| Lenz Therapeutics (LENZ) | 2.1 | $16M | 343k | 46.58 | |
| Aquestive Therapeutics (AQST) | 1.8 | $14M | 2.5M | 5.59 | |
| Palvella Therapeutics Inc Ne (PVLA) | 1.7 | $13M | 210k | 62.69 | |
| Avadel Pharmaceuticals Com Shs (AVDL) | 1.3 | $10M | 676k | 15.27 | |
| Vtv Therapeutics Cl A New (VTVT) | 1.1 | $8.7M | 375k | 23.35 | |
| Nkarta (NKTX) | 1.0 | $7.8M | 3.8M | 2.07 | |
| Contineum Therapeutics Cl A (CTNM) | 0.9 | $6.7M | 571k | 11.75 | |
| Arcellx Common Stock (ACLX) | 0.9 | $6.7M | 81k | 82.10 | |
| Abivax Sa Sponsored Ads (ABVX) | 0.8 | $6.4M | 75k | 84.90 | |
| Jade Biosciences Com New (JBIO) | 0.6 | $4.6M | 531k | 8.63 | |
| Aura Biosciences (AURA) | 0.5 | $3.6M | 585k | 6.18 | |
| Zymeworks Del (ZYME) | 0.5 | $3.6M | 208k | 17.08 | |
| Surrozen Com New (SRZN) | 0.4 | $3.1M | 241k | 12.88 | |
| Rhythm Pharmaceuticals (RYTM) | 0.4 | $3.1M | 30k | 100.99 | |
| Sutro Biopharma (STRO) | 0.2 | $1.9M | 2.2M | 0.87 | |
| Terns Pharmaceuticals (TERN) | 0.1 | $1.0M | 136k | 7.51 | |
| Bolt Biotherapeutics Com New (BOLT) | 0.0 | $260k | 49k | 5.32 | |
| Nuvation Bio *w Exp 02/10/202 (NUVB.WS) | 0.0 | $27k | 133k | 0.20 | |
| Surrozen *w Exp 08/01/203 (SRZNW) | 0.0 | $1.8k | 100k | 0.02 |
